At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LFWD Lifeward Ltd
Pre-Mkt 08-12 07:55:34 EDT
7.57
-0.14
-1.88%
High8.00Low7.50Vol3.62K
Open7.69D1 Closing7.71Amplitude6.48%
Mkt Cap21.29MTradable Cap11.19MTotal Shares2.81M
T/O27.83KT/O Rate0.24%Tradable Shares1.48M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Goldman Sachs: AI's Next Main Line Shifts From Computing Power To Humanoid Robots
Analyst Calls  ·  08-11 19:55
Goldman Sachs: AI's Next Main Line Shifts From Computing Power To Humanoid Robots
Lifeward Ltd Expected to Post a Loss of $1.34 a Share - Earnings Preview
Reuters  ·  08-10 21:16
Lifeward Ltd Expected to Post a Loss of $1.34 a Share - Earnings Preview
Lifeward to Report Q2 2026 Financial Results
Reuters  ·  08-07
Lifeward to Report Q2 2026 Financial Results
Lifeward Launches Pilot Program with Ottobock Care to Expand Access to ReWalk Personal Exoskeleton
Reuters  ·  08-05
Lifeward Launches Pilot Program with Ottobock Care to Expand Access to ReWalk Personal Exoskeleton
Nano Dimension Names Moshe Rozenbaum Interim CEO
Reuters  ·  07-22
Nano Dimension Names Moshe Rozenbaum Interim CEO
Lifeward Enters USD 5.58 Million Senior Secured Convertible Note Financing with Investors, Oramed Agent
Reuters  ·  07-08
Lifeward Enters USD 5.58 Million Senior Secured Convertible Note Financing with Investors, Oramed Agent
Press Release: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with up to $11.2 Million in Strategic Financing
Dow Jones  ·  07-08
Press Release: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with up to $11.2 Million in Strategic Financing
Lifeward Q1 FY26 net loss widens to $10.79 million; revenue drops 22% to $3.92 million
Reuters  ·  05-21
Lifeward Q1 FY26 net loss widens to $10.79 million; revenue drops 22% to $3.92 million
Lifeward files initial beneficial ownership statement for Chief Medical Officer Rose Keith Dale
Reuters  ·  05-20
Lifeward files initial beneficial ownership statement for Chief Medical Officer Rose Keith Dale
Lifeward names Keith D. Rose chief medical officer
Reuters  ·  05-19
Lifeward names Keith D. Rose chief medical officer
Press Release: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
Dow Jones  ·  05-19
Press Release: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
Lifeward Ltd reports results for the quarter ended March 31 - Earnings Summary
Reuters  ·  05-15
Lifeward Ltd reports results for the quarter ended March 31 - Earnings Summary
Lifeward delays Q1 10-Q filing, cites accounting work on strategic transaction
Reuters  ·  05-15
Lifeward delays Q1 10-Q filing, cites accounting work on strategic transaction
Lifeward Q1 Adj. EPS $(3.13) Misses $(1.25) Estimate, Sales $3.923M Miss $5.775M Estimate
Benzinga Earnings  ·  05-15
Lifeward Q1 Adj. EPS $(3.13) Misses $(1.25) Estimate, Sales $3.923M Miss $5.775M Estimate
Lifeward Q1 FY26 net loss more than doubles to $10.8 million; revenue falls 22% to $3.9 million
Reuters  ·  05-15
Lifeward Q1 FY26 net loss more than doubles to $10.8 million; revenue falls 22% to $3.9 million
Press Release: Lifeward Reports First Quarter 2026 Financial Results
Dow Jones  ·  05-15
Press Release: Lifeward Reports First Quarter 2026 Financial Results
Lifeward files initial beneficial ownership statement for Oramed Pharmaceuticals stake
Reuters  ·  05-15
Lifeward files initial beneficial ownership statement for Oramed Pharmaceuticals stake
Lifeward Ltd expected to post a loss of $1.25 a share - Earnings Preview
Reuters  ·  05-13
Lifeward Ltd expected to post a loss of $1.25 a share - Earnings Preview
Lifeward Ltd expected to post a loss of $1.25 a share - Earnings Preview
Reuters  ·  05-11
Lifeward Ltd expected to post a loss of $1.25 a share - Earnings Preview
Lifeward to report first-quarter 2026 results, host earnings call
Reuters  ·  05-11
Lifeward to report first-quarter 2026 results, host earnings call

Introduction

Company Name.
Lifeward Ltd
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--